Patents by Inventor Jingyun LI

Jingyun LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220144957
    Abstract: Provided are anti-IFNAR1 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.
    Type: Application
    Filed: January 23, 2020
    Publication date: May 12, 2022
    Inventors: Jingyun LI, Wei YE, Tao LIU, Xuyuan ZHANG, Liguo ZHANG, Guangxia GAO
  • Patent number: 11136399
    Abstract: The present disclosure discloses monoclonal antibodies binding to type I interferon alpha receptor and their uses. The antibodies are capable of inhibiting the biological activity of type I interferons, and can be used for treating, preventing, or diagnosing the diseases mediated by the type I interferons. Also provided are immunoconjugate, bispecific molecule and pharmaceutical compositions comprising the antibodies of the present disclosure.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: October 5, 2021
    Assignee: INSTITUTE OF BIOPHYSICS, CHINESE ACADEMY OF SCIENCES
    Inventors: Liguo Zhang, Lishan Su, Jingyun Li, Jianping Ma
  • Publication number: 20190389956
    Abstract: The present disclosure discloses monoclonal antibodies binding to type I interferon alpha receptor and their uses. The antibodies are capable of inhibiting the biological activity of type I interferons, and can be used for treating, preventing, or diagnosing the diseases mediated by the type I interferons. Also provided are immunoconjugate, bispecific molecule and pharmaceutical compositions comprising the antibodies of the present disclosure.
    Type: Application
    Filed: July 14, 2016
    Publication date: December 26, 2019
    Inventors: Liguo ZHANG, Lishan SU, Jingyun LI, Jianping MA